JP2002524508A - 新規組成物 - Google Patents
新規組成物Info
- Publication number
- JP2002524508A JP2002524508A JP2000569802A JP2000569802A JP2002524508A JP 2002524508 A JP2002524508 A JP 2002524508A JP 2000569802 A JP2000569802 A JP 2000569802A JP 2000569802 A JP2000569802 A JP 2000569802A JP 2002524508 A JP2002524508 A JP 2002524508A
- Authority
- JP
- Japan
- Prior art keywords
- component
- treatment
- composition
- treating
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803156-0 | 1998-09-16 | ||
| SE9803156A SE9803156D0 (sv) | 1998-09-16 | 1998-09-16 | A new composition |
| PCT/SE1999/001597 WO2000015218A1 (en) | 1998-09-16 | 1999-09-13 | A new composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002524508A true JP2002524508A (ja) | 2002-08-06 |
Family
ID=20412627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000569802A Pending JP2002524508A (ja) | 1998-09-16 | 1999-09-13 | 新規組成物 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1128825A1 (xx) |
| JP (1) | JP2002524508A (xx) |
| KR (1) | KR20010099647A (xx) |
| CN (1) | CN1317964A (xx) |
| AR (1) | AR021808A1 (xx) |
| AU (1) | AU6378099A (xx) |
| BR (1) | BR9913748A (xx) |
| CA (1) | CA2342341A1 (xx) |
| CZ (1) | CZ2001961A3 (xx) |
| EE (1) | EE200100157A (xx) |
| HU (1) | HUP0103544A3 (xx) |
| ID (1) | ID28785A (xx) |
| IL (1) | IL141519A0 (xx) |
| IS (1) | IS5879A (xx) |
| NO (1) | NO20011312L (xx) |
| PL (1) | PL346763A1 (xx) |
| SE (1) | SE9803156D0 (xx) |
| SK (1) | SK3262001A3 (xx) |
| TR (1) | TR200100779T2 (xx) |
| WO (1) | WO2000015218A1 (xx) |
| ZA (1) | ZA200101946B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9543601A (en) * | 2000-10-13 | 2002-04-22 | Neurosearch As | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| JPWO2006093192A1 (ja) * | 2005-03-04 | 2008-08-07 | 国立大学法人 東京医科歯科大学 | 覚醒剤精神病及び統合失調症の再発防止治療薬 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1998
- 1998-09-16 SE SE9803156A patent/SE9803156D0/xx unknown
-
1999
- 1999-09-13 ID IDW20010581A patent/ID28785A/id unknown
- 1999-09-13 CN CN99811010A patent/CN1317964A/zh active Pending
- 1999-09-13 CA CA002342341A patent/CA2342341A1/en not_active Abandoned
- 1999-09-13 IL IL14151999A patent/IL141519A0/xx unknown
- 1999-09-13 EE EEP200100157A patent/EE200100157A/xx unknown
- 1999-09-13 SK SK326-2001A patent/SK3262001A3/sk unknown
- 1999-09-13 CZ CZ2001961A patent/CZ2001961A3/cs unknown
- 1999-09-13 PL PL99346763A patent/PL346763A1/xx unknown
- 1999-09-13 BR BR9913748-8A patent/BR9913748A/pt not_active Application Discontinuation
- 1999-09-13 EP EP99951319A patent/EP1128825A1/en not_active Withdrawn
- 1999-09-13 AU AU63780/99A patent/AU6378099A/en not_active Abandoned
- 1999-09-13 HU HU0103544A patent/HUP0103544A3/hu unknown
- 1999-09-13 TR TR2001/00779T patent/TR200100779T2/xx unknown
- 1999-09-13 JP JP2000569802A patent/JP2002524508A/ja active Pending
- 1999-09-13 WO PCT/SE1999/001597 patent/WO2000015218A1/en not_active Application Discontinuation
- 1999-09-13 KR KR1020017003337A patent/KR20010099647A/ko not_active Application Discontinuation
- 1999-09-15 AR ARP990104626A patent/AR021808A1/es not_active Application Discontinuation
-
2001
- 2001-03-07 IS IS5879A patent/IS5879A/is unknown
- 2001-03-08 ZA ZA200101946A patent/ZA200101946B/en unknown
- 2001-03-15 NO NO20011312A patent/NO20011312L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL141519A0 (en) | 2002-03-10 |
| EE200100157A (et) | 2002-08-15 |
| NO20011312D0 (no) | 2001-03-15 |
| IS5879A (is) | 2001-03-07 |
| HUP0103544A2 (hu) | 2002-05-29 |
| ID28785A (id) | 2001-07-05 |
| WO2000015218A1 (en) | 2000-03-23 |
| TR200100779T2 (tr) | 2001-10-22 |
| PL346763A1 (en) | 2002-02-25 |
| EP1128825A1 (en) | 2001-09-05 |
| SK3262001A3 (en) | 2001-08-06 |
| KR20010099647A (ko) | 2001-11-09 |
| ZA200101946B (en) | 2002-06-10 |
| AU6378099A (en) | 2000-04-03 |
| CA2342341A1 (en) | 2000-03-23 |
| NO20011312L (no) | 2001-05-16 |
| AR021808A1 (es) | 2002-08-07 |
| SE9803156D0 (sv) | 1998-09-16 |
| BR9913748A (pt) | 2001-07-10 |
| CN1317964A (zh) | 2001-10-17 |
| HUP0103544A3 (en) | 2003-12-29 |
| CZ2001961A3 (cs) | 2001-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI294779B (en) | Use of optically pure (s,s)-reboxetine in the manufacture of a medicament for the treatment or prevention of peripheral neuropathy | |
| US6169098B1 (en) | Composition and methods employing it for the treatment of 5-HT-mediated disorders | |
| JP2008538784A (ja) | 膀胱機能を調節するための方法 | |
| JP2002542287A (ja) | 医 薬 | |
| WO2007093624A2 (en) | Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin | |
| JP2002515435A (ja) | 鬱病処置のための組合せ治療 | |
| JP2005505539A (ja) | パーキンソン病の治療のためのｃｂ１受容体アンタゴニストと、脳のドーパミン作用性神経伝達を活性化する製品を含む組成物 | |
| KR20040030788A (ko) | 요실금 치료를 위한 아릴(또는 헤테로아릴)아졸릴카르비놀 유도체 | |
| JP2003530353A (ja) | オルチプラズの肝繊維化及び肝硬変症進行の予防及び治療剤としての使用方法、及びオルチプラズを主成分として含有する製薬組成物 | |
| JP2002511414A (ja) | 神経疾患のための新しい治療 | |
| JP2002531402A (ja) | 新規な医薬組成物 | |
| JP2002524508A (ja) | 新規組成物 | |
| JP2002524509A (ja) | 新規組成物 | |
| JP2005513105A (ja) | 臨床的うつ病を治療するためのデオキシペガニンの使用 | |
| JP2002524510A (ja) | 新規組成物 | |
| JP2002524507A (ja) | 新規組成物 | |
| JP2002511408A (ja) | 神経疾患のための新しい治療 | |
| WO2001093844A2 (en) | Compositions comprising a serotonin transporter inhibitor and a 5-ht1d antagonist | |
| TW202243675A (zh) | 焦慮症處置用組成物及處置方法 | |
| JP2002532548A (ja) | いびきおよび解剖学的上気道の高抵抗症候群を治療するための薬剤を製造するための５ｈｔ２ａおよび５ｈｔ２ａ／ｃ受容体アンタゴニストの使用 | |
| MXPA01002370A (en) | A new composition | |
| MX2008012212A (es) | Metodos para tratar trastornos cognitivos y otros afines. | |
| MXPA01002543A (en) | A new composition | |
| JP2017039645A (ja) | 網膜疾患の予防又は治療のための医薬 |